OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← ZEO management

Full background report

Shane Graham

Executive Director

Career chronology

  • More than 20 years before Holcim: Boral Limited — Executive General Management roles, including Queensland and Major Projects / PMO. Our People (Our People, Shane Graham biography, lines 65–70)

  • Five years before Zeotech: Holcim Australia — Executive General Manager – Commercial & Major Projects; later EGM – Humes Australia. Our People (Our People, Shane Graham biography, lines 65–70)

  • From 7 April 2025: Zeotech Limited — Executive Director (Technical). Annual Report 2025 (p. 23, service agreement effective date and role)

Education and qualifications

Education and professional qualification

As reported by cited source; accessed 2026-10-09 · issuer reported · low materiality

The issuer reports an MBA from Queensland University of Technology. The credential was not independently verified.

Attribution: Responsibility not applicable. Credential statements are issuer-reported; no university or professional-body verification was obtained.

Relevance: Relevant to role-fit assessment and subject to verification gap.

Our People (Our People, Shane Graham biography, lines 65–70)

Contributions and company outcomes

FY2026 project and commercial milestones

FY2026 through 2026-06-30; subsequent status through 2026-09-21 · issuer reported · medium materiality

During the cited period Zeotech reported the binding MSI DSO offtake, 2,300-tonne test-pit campaign, AusPozz concrete demonstration and methane-control field results, while Toondoon remained pre-commercial with approvals/logistics still progressing. These are company-level outcomes; the evidence does not isolate executive director's personal contribution or establish booked DSO/AusPozz sales.

Attribution: Role overlaps event; causation unproven. Management responsibility overlapped the company period, but personal causal contribution is not documented.

Relevance: Relevant to delivery assessment; distinguish test/contract milestones from commercial production and realized cash revenue.

Annual Report to shareholders (FY2026 annual report, operating review; his Zeotech tenure began April 2025); Quarterly Activities and Appendix 5B Cash Flow Report (pp. 1–8, activities report)

Suitability for the current role

Role relevance and evidenced background

Background reviewed through 2026-10-09 · analyst inference · low materiality

The issuer biography supports relevant background for the assigned role. Current title in the selected roster: Executive Director. This supports role relevance at a high level; the public evidence reviewed does not establish personal causal responsibility for employer or project outcomes.

Attribution: Responsibility not applicable. Role-fit judgment based on the selected roster and issuer-reported professional background; no causal claim is made.

Relevance: Relevant to the current Executive Director responsibilities, subject to the evidence limitations recorded below.

Our People (Executive biography or corporate-directory entry for the named person)

Evidence gaps

  • Prior-career date granularity and qualifications are mainly issuer-reported and not independently verified.

  • Company milestones are not personally attributable from available evidence; the company remained pre-commercial at the cutoff.

  • No exhaustive criminal, sanctions, court, regulator, safety, environment or qualification check was performed.